Paradigm Biopharmaceuticals Ltd
News & analysis
Times are shown in GMT+11, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
Paradigm Biopharmaceuticals Ltd is a biopharmaceutical company that engages in the research and development of therapeutic products for human use in Australia. The firm is engaged in drug repurposing, pentosan polysulphate sodium (PPS) for the lead clinical indication of bone marrow edema, Alphavirus - Ross River virus (RRV) and Chikungunya virus (CHIKV), Mucopolysaccharidosis, and allergic respiratory conditions, including allergic rhinitis (AR) and chronic obstructive pulmonary disease (COPD).Paradigm Biopharmaceuticals Ltd is a biopharmaceutical company. The Company is engaged in drug repurposing, pentosan polysulphate sodium (PPS) for the lead clinical indication of bone marrow edema.
Latest PAR News